Cambridge Healthtech Institute’s 19th Annual
Digital Transformation & AI in Bioprocess
Intelligent Bioprocess: Simulate, Predict, Control
June 15-16, 2027
Biopharmaceutical manufacturers are under increasing pressure to improve yield, ensure consistent product quality, accelerate process development, and reduce manufacturing costs. Digital twins, AI, and advanced process control offer new ways to meet these demands, but translating promising technologies into reliable manufacturing solutions remains a challenge. The Digital Transformation & AI in Bioprocess track focuses on putting these tools to work, from integrating process data and predicting performance to optimizing operations and enabling real-time control. Industry experts will share practical applications, implementation challenges, and lessons learned in moving from digital models and AI-driven insights to measurable improvements in bioprocess performance.
Coverage will include, but is not limited to:
- Data Integration and Management
- Integrating process, analytical, and quality data across the product lifecycle
- Improving data quality, standardization, and contextualization
- Breaking down data silos to support AI and process modeling
- Enabling data reuse across development, scale-up, and manufacturing
- Digital Twins and Process Modeling
- Digital twins for process simulation, optimization, and control
- Hybrid models combining mechanistic approaches and machine learning
- Digital twins for upstream and downstream processing
- Scale-up prediction and model transfer across sites
- AI/ML for Process Development and Optimization
- AI for design of experiments, media optimization, and cell-culture development
- Predictive modeling for upstream and downstream processes
- Improving yield, productivity, and process robustness
- Active learning to accelerate process development
- Process Analytical Technology and Predictive Quality
- AI-enabled real-time monitoring and soft sensors
- Predicting critical quality attributes and process deviations
- Sensor fusion, pattern recognition, and anomaly detection
- Using process data to support timely manufacturing decisions
- Advanced Process Control
- Model-predictive and adaptive process control
- AI-driven feed optimization and process adjustments
- Integrating PAT, digital twins, and automated control
- Moving from process predictions to closed-loop control
- Automation and Self-Driving Laboratories
- Robotics and automated platforms for process development
- AI-guided experimentation and optimization
- Automated design-build-test-learn workflows
- Connecting experimental results to subsequent experiments
- Generative and Agentic AI in Bioprocessing
- Generative AI for process-knowledge management and troubleshooting
- AI-assisted deviation investigation and root-cause analysis
- Agentic AI for coordinating tools and operational workflows
- Human oversight of AI-generated recommendations and actions
- AI Implementation and Regulatory Readiness
- Validating AI/ML models for biomanufacturing applications
- Integrating AI into quality-by-design and process-lifecycle management
- Monitoring model performance, drift, and reliability
- Ensuring data integrity, traceability, and appropriate governance
The deadline for priority consideration is November 20, 2026.
All proposals are subject to review by session chairpersons and/or the Scientific Advisory Committee to ensure the overall quality of the conference program. Additionally, as per Cambridge Healthtech Institute’s policy, a select number of vendors and consultants who provide products and services will be offered opportunities for podium presentation slots based on a variety of Corporate Sponsorships.
Opportunities for Participation:
- To submit a podium presentation, please click here.
- To become a sponsor, click here.
- To present a poster, click here.
- To sign up to attend, click here.